63 related articles for article (PubMed ID: 30471863)
1. Overexpressing kringle 1 domain of hepatocyte growth factor with adeno-associated virus inhibits the pathological retinal neovascularization in an oxygen-induced retinopathy mouse model.
Sun P; Liu Z
Biochem Biophys Res Commun; 2019 Jan; 508(1):130-137. PubMed ID: 30471863
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization.
Raisler BJ; Berns KI; Grant MB; Beliaev D; Hauswirth WW
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8909-14. PubMed ID: 12072560
[TBL] [Abstract][Full Text] [Related]
3. GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis.
Xu X; Ding X; Wang Z; Ye S; Xu J; Liang Z; Luo R; Xu J; Li X; Ren Z
Microvasc Res; 2024 Jul; 154():104689. PubMed ID: 38636926
[TBL] [Abstract][Full Text] [Related]
4. Recombinant thrombomodulin domain 1 rescues pathological angiogenesis by inhibition of HIF-1α-VEGF pathway.
Huang YH; Kuo CH; Peng IC; Chang YS; Tseng SH; Conway EM; Wu HL
Cell Mol Life Sci; 2021 Dec; 78(23):7681-7692. PubMed ID: 34705054
[TBL] [Abstract][Full Text] [Related]
5. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization.
Suzuma K; Takagi H; Otani A; Oh H; Honda Y
Am J Pathol; 1999 Feb; 154(2):343-54. PubMed ID: 10027393
[TBL] [Abstract][Full Text] [Related]
6. A drug-tunable Flt23k gene therapy for controlled intervention in retinal neovascularization.
Chen J; Lin FL; Leung JYK; Tu L; Wang JH; Chuang YF; Li F; Shen HH; Dusting GJ; Wong VHY; Lisowski L; Hewitt AW; Bui BV; Zhong J; Liu GS
Angiogenesis; 2021 Feb; 24(1):97-110. PubMed ID: 32935224
[TBL] [Abstract][Full Text] [Related]
7. Suppression of retinal neovascularization by intravitreal injection of cryptotanshinone.
Yu Y; Qin X; Chen X; Nie H; Li J; Yao J
Biochem Biophys Res Commun; 2024 Aug; 720():150065. PubMed ID: 38749188
[TBL] [Abstract][Full Text] [Related]
8. Elimination of Signaling by the Luteinizing Hormone Receptor Reduces Ocular VEGF and Retinal Vascularization during Mouse Eye Development.
Movsas TZ; Sigler R; Muthusamy A
Curr Eye Res; 2018 Oct; 43(10):1286-1289. PubMed ID: 29966451
[TBL] [Abstract][Full Text] [Related]
9. RhoA/ROCK Signaling Is Involved in Pathological Retinal Neovascularization.
Tang F; Huang K; Peng B; Deng W; Su N; Xu F; Zhang M; Zhong H
J Vasc Res; 2023; 60(4):183-192. PubMed ID: 37660689
[TBL] [Abstract][Full Text] [Related]
10. The alternative complement pathway aids in vascular regression during the early stages of a murine model of proliferative retinopathy.
Kim C; Smith KE; Castillejos A; Diaz-Aguilar D; Saint-Geniez M; Connor KM
FASEB J; 2016 Mar; 30(3):1300-5. PubMed ID: 26631482
[TBL] [Abstract][Full Text] [Related]
11. Astrocytic expression of Yes-associated protein (YAP) regulates retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Liu Z; Zhang J; Li X; Hu Q; Chen X; Luo L; Ai L; Ye J
Microvasc Res; 2024 Jan; 151():104611. PubMed ID: 37774941
[TBL] [Abstract][Full Text] [Related]
12. Cone cell dysfunction attenuates retinal neovascularization in oxygen-induced retinopathy mouse model.
Wu J; Jo DH; Fruttiger M; Kim JH
J Neurosci Res; 2024 Mar; 102(3):e25316. PubMed ID: 38415926
[TBL] [Abstract][Full Text] [Related]
13. Ferrochelatase regulates retinal neovascularization.
Pran Babu SPS; White D; Corson TW
FASEB J; 2020 Sep; 34(9):12419-12435. PubMed ID: 32716567
[TBL] [Abstract][Full Text] [Related]
14. Identification of different macrophage subpopulations with distinct activities in a mouse model of oxygen-induced retinopathy.
Zhu Y; Zhang L; Lu Q; Gao Y; Cai Y; Sui A; Su T; Shen X; Xie B
Int J Mol Med; 2017 Aug; 40(2):281-292. PubMed ID: 28627621
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional Imaging Coupled with Topological Quantification Uncovers Retinal Vascular Plexuses Undergoing Obliteration.
Chang CC; Chu A; Meyer S; Ding Y; Sun MM; Abiri P; Baek KI; Gudapati V; Ding X; Guihard P; Bostrom KI; Li S; Gordon LK; Zheng JJ; Hsiai TK
Theranostics; 2021; 11(3):1162-1175. PubMed ID: 33391527
[No Abstract] [Full Text] [Related]
16. Aurora kinase B disruption suppresses pathological retinal angiogenesis by affecting cell cycle progression.
Zhu W; Gui X; Zhou Y; Gao X; Zhang R; Li Q; Zhang H; Zhao J; Cui X; Gao G; Tang H; Huan C; Pan D; Song H; Zhou Z; Shen W
Exp Eye Res; 2024 Feb; 239():109753. PubMed ID: 38142764
[TBL] [Abstract][Full Text] [Related]
17. Interplay between CCN1 and Wnt5a in endothelial cells and pericytes determines the angiogenic outcome in a model of ischemic retinopathy.
Lee S; Elaskandrany M; Lau LF; Lazzaro D; Grant MB; Chaqour B
Sci Rep; 2017 May; 7(1):1405. PubMed ID: 28469167
[TBL] [Abstract][Full Text] [Related]
18. FOXC1 regulates endothelial CD98 (LAT1/4F2hc) expression in retinal angiogenesis and blood-retina barrier formation.
Bhakuni T; Norden PR; Ujiie N; Tan C; Lee SK; Tedeschi T; Hsieh YW; Wang Y; Liu T; Fawzi AA; Kume T
Nat Commun; 2024 May; 15(1):4097. PubMed ID: 38755144
[TBL] [Abstract][Full Text] [Related]
19. Targeting Neurovascular Interaction in Retinal Disorders.
Fu Z; Sun Y; Cakir B; Tomita Y; Huang S; Wang Z; Liu CH; S Cho S; Britton W; S Kern T; Antonetti DA; Hellström A; E H Smith L
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098361
[TBL] [Abstract][Full Text] [Related]
20. IL-33 enhances Jagged1 mediated NOTCH1 intracellular domain (NICD) deubiquitination and pathological angiogenesis in proliferative retinopathy.
Sharma D; Bisen S; Kaur G; Van Buren EC; Rao GN; Singh NK
Commun Biol; 2022 May; 5(1):479. PubMed ID: 35589941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
